Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteblazebioscience.com
CategoryBioTech
Emailinfo@blazebioscie...
Employees
Founded2010
DescriptionBiotechnology company

Offices

Seattle, USA
P.O. Box 61323
Seattle, WA, 98141-6323
USA

People

President and Chief Executive Officer
Vice President, Finance and Operations
Vice President, Research and Project Management
Senior Director of Process Development and Manufacturing
Scientific Founder, Chair of Scientific Advisory Board
Board Secretary, Chair of Audit Committee

Funding

TOTAL $22.5M
FUNDING TOTAL $22.5M
Series A, 6/2012
$5M
Series A, 2/2013
$8.5M
Series B, 12/2013
$9M
DEBT TOTAL $725k
Debt, 10/2011
$725k

Tags

Blaze Bioscience

Blaze Bioscience is a Seattle-based, privately-held biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients. The company was founded in 2010 to develop and commercialize the Tumor Paint technology. Tumor Paint provides real-time, highresolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer. The first Tumor Paint product candidate, which is a combination of a targeting peptide and a fluorescent beacon, is under development for multiple solid tumors.

Recent Milestones

Videos

Screenshots

Blaze Bioscience screenshot
Above: Blaze Bioscience
Uploaded: 6/9/12

Sources

  1. SEC (sec.gov) [edit]
  2. Blaze Bioscience R aises $ 5.0 million in Series A Financing (blazebioscience.com) [edit]
  3. Blaze Bioscience Completes $8.5M Series A Financing (finsmes.com) [edit]
  4. Blaze Bioscience Raises $9M in Series B Financing (finsmes.com) [edit]
Edit This Page
Last Edited 12/3/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy